Jogiraju Tantravahi, M.D.

Jogiraju V Tantravahi, M.D., Ph.D.

(352) 265-4845

Request an Appointment

Publications

History solves the mystery: an unusual cause of hypercalcemia.
CEN case reports
2019

Nephrotic syndrome in very elderly: Should we treat aggressively?
Clinics and practice
2018

IgA nephropathy in African Americans: uncommon but possible.
JRSM open
2018

Testicular angina in a hemodialysis patient: expect the unexpected.
Clinical and experimental nephrology
2017

The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic.
Journal of the American Society of Hypertension : JASH
2015

Drug Induced Cholestasis Triggered By Quetiapine
Journal of Investigative Medicine
2009

Why hasn't eliminating acute rejection improved graft survival?
Annual review of medicine
2007

Hyperfiltration: a sign of poor things to come in individuals with metabolic syndrome.
Nature clinical practice. Nephrology
2007

Acquired cystic kidney disease.
Seminars in dialysis
2000

Characterization of the mouse beta maj globin transcription termination region: a spacing sequence is required between the poly(A) signal sequence and multiple downstream termination elements.
Molecular and cellular biology
1993

Research Interests

  • Dr. Tantravahi's predominant academic interest centers on education. He has mentored several medical students and residents as an instruction in the 1st year medical student Medical Physiology course, the Essentials of Patient Care course, and during their rotations as third and fourth year clerks on the inpatient Internal Medicine and Nephrology rotations. Since July, 2010 Dr. Tantravahi has been the Nephrology Fellowship Training Program Director and has made improvement in nephrology education his primary academic focus.
  • Dr. Tantravahi's clinical interests are varied and include the care of patients with chronic kidney disease and end stage renal disease, glomerulonephritis, kidney stones, and the management of kidney disease in pregnancy. Currently, Dr. Tantravahi's practice includes several end stage renal disease patients who are treated with both hemodialysis and peritoneal dialysis. He precepts fellows in two large clinics (at the Malcom Randall VA Medical Center and the University of Florida Internal Medicine and Medical Specialties Clinic) where he, in conjunction with renal fellows at the University of Florida, manages outpatients with a variety of renal conditions.